Ethnicity and Cardiovascular Risk Factor Control in Patients with Type 2 Diabetes

ethnicity concept, images of people in a variety of colorsIn a study, researchers from Malaysia looked at cardiovascular risk factor control among the various ethnic groups living in Malaysia who have type 2 diabetes.

The results of their study appeared online at the end of December 2011 in the article “Does ethnicity contribute to the control of cardiovascular risk factors among patients with type 2 diabetes?” The article will appear in the Asia-Pacific Journal of Public Health.

For this study, the research team used the Malaysian diabetes registry database and analyzed data of 70,092 adults from that database.

What Did Researchers Learn about Ethnicity and Cardiovascular Risk Factor Control?
When researchers analyzed these data, they found that the Malays had the overall worst achievement of target for the majority of the cardiovascular risk factors.

The researchers also found that the Indians living in Malaysia had poor achievement of control for both waist circumference (odds ratio [OR]=0.6; 95% confidence interval [CI]=0.6 to 0.7) and high-density lipoprotein cholesterol (OR=0.5; 95% CI=0.4 to 0.5).

In addition, researchers found that compared with the Malays, Chinese living in Malaysia had a better achievement of target control for the various cardiovascular risk factors. These risk factors include body mass index (OR=1.3; 95% CI=1.2 to 1.4), blood pressure (OR=1.3; 95% CI=1.3 to 1.4), and total cholesterol (OR=1.7; 95% CI=1.6 to 1.8).

They observed that the Chinese also had a better achievement of target control for low-density lipoprotein cholesterol (OR=1.7; 95% CI=1.6 to 1.8), glycated hemoglobin (HbA1c) (OR=1.4; 95% CI=1.3 to 1.4), and fasting blood glucose (OR=1.4; 95% CI=1.3 to 1.5) when compared with the Malays.

At the end of the study, the research team concluded that a variety of factors—including ethnicity, sociocultural factors, and psychobehavioral factors—should be addressed in creating management strategies to control cardiovascular risk factors in patients who have type 2 diabetes.

Continue Reading:
Advanced Glycation Endproduct Accumulation Linked to Decreased Bone Material Strength in Type 2 Diabetes
SHOW MAIN MENU
SHOW SUB MENU